• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Ireland
    • Novartis Website Directory
Novartis Logo: a global healthcare company
  • Our Work
    • Therapeutic Areas
    • Clinical Trials
    • Product Portfolio
    • Our Process
  • About Us
    • Who We Are
    • Our Business
    • Corporate Responsibility
    • Contact Us
  • For Patients
    • Commitment to Patients and Caregivers
    • Working with Patient Groups
  • News
    • Stories
    • Media Contacts
  • Careers
    • Career Search
    • Working at Novartis Ireland
    • Employee Benefits
    • Awards & Recognition
Search
Novartis and Microsoft AI Collaboration
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Medicines

Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence

Oct 07, 2019

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and selecting Microsoft as its strategic artificial intelligence and data-science partner for this effort. The new lab aims to bolster Novartis’ AI capabilities from research through commercialization and help accelerate the discovery and development of transformative medicines for patients worldwide.


Joint research activities will include co-working environments on Novartis Campus (Switzerland), at Novartis Global Service Center in Dublin, and at Microsoft Research Lab (UK) – starting with tackling personalized therapies for macular degeneration, cell & gene therapy and drug design.


As part of the strategic collaboration announced, Novartis and Microsoft have committed to a multi-year research and development effort. This strategic alliance will focus on two core objectives:

  1. AI Empowerment. The lab will aim to bring the power of AI to the desktop of every Novartis associate. By bringing together vast amounts of Novartis datasets with Microsoft’s advanced AI solutions, the lab will aim to create new AI models and applications that can augment our associates’ capabilities to take on the next wave of challenges in medicine.
  2. AI Exploration. The lab will use the power of AI to tackle some of the hardest computational challenges within life sciences, starting with generative chemistry, image segmentation & analysis for smart and personalized delivery of therapies and optimization of cell & gene therapies at scale.

Microsoft and Novartis will also collaborate to develop and apply next-generation AI platforms and processes that support future programs across these two focus areas. The overall investment will include project funding, subject-matter experts, technology, and tools.


Vas Narasimhan, CEO of Novartis, said, “As Novartis continues evolving into a focused medicines company powered by advanced therapy platforms and data science, alliances like this will help us deliver on our purpose to reimagine medicine to improve and extend patients’ lives. Pairing our deep knowledge of human biology and medicine with Microsoft’s leading expertise in AI could transform the way we discover and develop medicines for the world.”


Microsoft CEO, Satya Nadella, added, “Our strategic alliance will combine Novartis' life sciences expertise with the power of Azure and Microsoft AI. Together, we aim to address some of the biggest challenges facing the life sciences industry today and bring AI capabilities to every Novartis employee so they can unlock new insights as they work to discover new medicines and reduce patient costs.”
 

Disclaimer: 

IE02/GEA19-CNF009  September 2019

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Raymond P Murphy Neurology Assessment & Research Unit
Medicines

New Neurology Research & Assessment Unit officially opened at Tallaght Hospital

New report reveals that Multiple Sclerosis costs Irish society more than 429 million euros each year
Medicines

New report reveals that Multiple Sclerosis costs Irish society more than 429 million euros each year

Hospital pharmacy awards 2015
Medicines

Novartis Sponsor the Hospital Pharmacy News, Innovation and Service Development Award for 2015

You are here

  1. Home ›
  2. Stories

Novartis Ireland

  • News
  • Careers
  • About Us
  • Contact Us
  • For Patients
  • Locations
  • Our Work

Subscribe to Novartis

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
  • Email
  • Novartis Site Directory
© 2019 Novartis AG

This site is intended for an audience in Ireland.

  • Terms of Use
  • Privacy Policy
  • About Cookies